(Q42554253)

English

Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial inject

scientific article published on 30 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial inject (English)

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

dilated cardiomyopathy

1 reference

based on heuristic

inferred from title

author name string

Muzammil Mushtaq

1

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Darcy L DiFede

2

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Samuel Golpanian

3

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Aisha Khan

4

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Samirah A Gomes

5

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Adam Mendizabal

6

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Alan W Heldman

7

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Joshua M Hare

8

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

language of work or name

0 references

publication date

30 October 2014

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Journal of Cardiovascular Translational Research

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

7

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

9

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

769-780

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

https://scigraph.springernature.com/pub.10.1007/s12265-014-9594-0

0 references

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

A characterization and targeting of the infarct border zone in a swine model of myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Transcriptomic biomarkers for the accurate diagnosis of myocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Transcriptomic biomarkers for individual risk assessment in new-onset heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

The Seattle Heart Failure Model: prediction of survival in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Do we have a future with transcatheter adventitial delivery of stem cells?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

Third Universal Definition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9594-0

21 January 2018

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9594-0

21 January 2018

Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

3 November 2018

Pressure overload leads to an increase of cardiac resident stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9594-0

21 January 2018

Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The variable natural history of idiopathic dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A safety and feasibility study of cell therapy in dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Embryonic Stem Cells and Released Factors Stimulate c-kit(+)/FLK-1(+) Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12265-014-9594-0

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42554253&oldid=1575317402"